Ashley A. Smith

490 total citations
8 papers, 366 citations indexed

About

Ashley A. Smith is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ashley A. Smith has authored 8 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Molecular Biology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ashley A. Smith's work include Epigenetics and DNA Methylation (2 papers), Adenosine and Purinergic Signaling (1 paper) and Phagocytosis and Immune Regulation (1 paper). Ashley A. Smith is often cited by papers focused on Epigenetics and DNA Methylation (2 papers), Adenosine and Purinergic Signaling (1 paper) and Phagocytosis and Immune Regulation (1 paper). Ashley A. Smith collaborates with scholars based in United States. Ashley A. Smith's co-authors include K.F. Siu, H. Y. Cheung, Raphael C. Lui, J. Wong, Carmen J. Marsit, Karl T. Kelsey, John K. Wiencke, E. Andrés Houseman, Margaret R. Karagas and Devin C. Koestler and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Journal of Pediatric Surgery.

In The Last Decade

Ashley A. Smith

8 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley A. Smith United States 5 145 141 138 127 94 8 366
Wolfgang Stiglbauer Austria 7 141 1.0× 101 0.7× 112 0.8× 52 0.4× 70 0.7× 9 390
Thong Quang Pham Vietnam 8 73 0.5× 82 0.6× 36 0.3× 73 0.6× 36 0.4× 11 326
Hanh Thi Tuyet Ngo Vietnam 9 64 0.4× 81 0.6× 45 0.3× 80 0.6× 34 0.4× 14 338
Noémi Nagy Hungary 10 164 1.1× 39 0.3× 66 0.5× 71 0.6× 100 1.1× 26 317
Natacha Martin France 8 216 1.5× 40 0.3× 189 1.4× 33 0.3× 145 1.5× 15 380
Hairui Sun China 9 122 0.8× 54 0.4× 57 0.4× 37 0.3× 32 0.3× 24 269
Julia Sun United States 7 193 1.3× 126 0.9× 56 0.4× 20 0.2× 74 0.8× 8 331
Feiying Gu China 10 133 0.9× 28 0.2× 94 0.7× 51 0.4× 55 0.6× 11 316
Nicolas Whenham Belgium 7 87 0.6× 42 0.3× 64 0.5× 79 0.6× 26 0.3× 17 234

Countries citing papers authored by Ashley A. Smith

Since Specialization
Citations

This map shows the geographic impact of Ashley A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley A. Smith more than expected).

Fields of papers citing papers by Ashley A. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley A. Smith. The network helps show where Ashley A. Smith may publish in the future.

Co-authorship network of co-authors of Ashley A. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley A. Smith. A scholar is included among the top collaborators of Ashley A. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley A. Smith. Ashley A. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Katz, Liora S., Ashley A. Smith, Jennifer C. Dunn, et al.. (2021). Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage. Molecular Metabolism. 54. 101347–101347. 20 indexed citations
2.
Smith, Ashley A., et al.. (2018). Pharmacological Agents Utilized in Patients With Type-2 Diabetes: Beyond Lowering A1c.. PubMed. 43(4). 214–227. 2 indexed citations
3.
Smith, Ashley A., Adam S. Wilson, & David R. Soto‐Pantoja. (2017). Abstract 5661: Targeting CD47 expression on macrophages regulates immunometabolism enhancing tumoricidal activity against cancer cells. Cancer Research. 77(13_Supplement). 5661–5661. 1 indexed citations
4.
Smith, Ashley A., Yen‐Tsung Huang, Melissa Eliot, et al.. (2014). A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression. Epigenetics. 9(6). 873–883. 24 indexed citations
5.
Christensen, Brock C., Ashley A. Smith, Shichun Zheng, et al.. (2010). DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma. JNCI Journal of the National Cancer Institute. 103(2). 143–153. 192 indexed citations
6.
Smith, Ashley A., et al.. (2003). Melanoma from the dermatologist's perspective. Facial Plastic Surgery Clinics of North America. 11(2). 277–286. 1 indexed citations
7.
Smith, Ashley A. & Nicodème Sinzobahamvya. (1992). Anterior mediastinal abscess complicating septic arthritis. Journal of Pediatric Surgery. 27(1). 101–102. 7 indexed citations
8.
Wong, J., et al.. (1987). Esophagogastric anastomosis performed with a stapler: the occurrence of leakage and stricture.. PubMed. 101(4). 408–15. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026